WordNet
- limit, block, or decrease the action or function of; "inhibit the action of the enzyme"; "inhibit the rate of a chemical reaction"
- control and refrain from showing; of emotions, desires, impulses, or behavior (同)bottle up, suppress
- limit the range or extent of; "Contact between the young was inhibited by strict social customs"
- a substance that retards or stops an activity
PrepTutorEJDIC
- 〈感情・欲望・行動・作用など〉‘を'抑制する / (…しないように)〈人〉‘を'抑制する,妨げる《+『名』+『from』+『名』(do『ing』)》
- 抑制する人(物) / 化学反応抑制剤
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/05/23 00:52:05」(JST)
[Wiki en表示]
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2013) (Learn how and when to remove this template message) |
A matrix metalloproteinase inhibitor (MMPI) inhibits matrix metalloproteinases. As they inhibit cell migration they have antiangiogenic effects. They may be both endogenous and exogenous.
The most notorious endogenous metalloproteinases are tissue inhibitors of metalloproteinases (TIMPs). There are also cartilage-derived angiogenesis inhibitors.
Exogenous matrix metalloproteinase inhibitors that were developed as anticancer drugs include batimastat and marimastat.
Metalloproteinase inhibitors are found in numerous marine organisms, including fish, cephalopods, mollusks, algea and bacteria.[1]
See also
- Drug discovery and development of MMP inhibitors
References
- ^ Noel Vinay Thomas, Se Kwon Kim (2010). "Metalloproteinase Inhibitors Stts and Scope from Marine Organisms". Biochemistry Research International 2010: 845975. doi:10.1155/2010/845975. PMC 3004377. PMID 21197102.
Pharmacology: enzyme inhibition
|
|
Class |
- Competitive inhibition
- Uncompetitive inhibition
- Non-competitive inhibition
- Suicide inhibition
- Mixed inhibition
|
|
Substrate |
Oxidoreductase (EC 1) |
- 1.1 Aldose reductase
- HMG-CoA reductase
- 1.5 Dihydrofolate reductase
- 1.17 Xanthine oxidase
- Ribonucleotide reductase
|
|
Transferase (EC 2) |
- 2.1 COMT
- Thymidylate synthase
- 2.5 Dihydropteroate synthetase
- Farnesyltransferase
- 2.7 Nucleotidyltransferase
- Integrase
- Reverse transcriptase
- Protein kinase
|
|
Hydrolase (EC 3) |
- 3.1 Phosphodiesterase
- Acetylcholinesterase
- Ribonuclease
- 3.2 Polygalacturonase
- Neuraminidase
- Alpha-glucosidase
- 3.4 Protease: Exopeptidase
- Endopeptidase
- Mixed
- Enkephalinase
- Matrix metalloproteinase
- Oxytocinase
- 3.5 Histone deacetylase
- Beta-lactamase
|
|
Lyase (EC 4) |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
- Imeri F1, Fallegger D1, Zivkovic A2, Schwalm S3, Enzmann G4, Blankenbach K3, Meyer Zu Heringdorf D3, Homann T5, Kleuser B5, Pfeilschifter J3, Engelhardt B4, Stark H2, Huwiler A6.
- Neuropharmacology.Neuropharmacology.2014 Oct;85:314-27. doi: 10.1016/j.neuropharm.2014.05.012. Epub 2014 May 23.
- The immunomodulatory FTY720 (fingolimod) is presently approved for the treatment of relapsing-remitting multiple sclerosis. It is a prodrug that acts by modulating sphingosine 1-phosphate (S1P) receptor signaling. In this study, we have developed and characterized two novel oxazolo-oxazole derivativ
- PMID 24863045
- In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts.
- Nijhuis A1, Biancheri P2, Lewis A1, Bishop CL3, Giuffrida P2, Chan C4, Feakins R5, Poulsom R1, Di Sabatino A6, Corazza GR6, MacDonald TT2, Lindsay JO1, Silver AR1.
- Clinical science (London, England : 1979).Clin Sci (Lond).2014 Sep;127(5):341-50. doi: 10.1042/CS20140048.
- Intestinal fibrosis with stricture formation is a complication of CD (Crohn's disease) that may mandate surgical resection. Accurate biomarkers that reflect the relative contribution of fibrosis to an individual stricture are an unmet need in managing patients with CD. The miRNA-29 (miR-29) family h
- PMID 24641356
- Effects of polycystin‑1 N‑terminal fragment fusion protein on the proliferation and apoptosis of rat mesangial cells.
- Guan T1, Gao Q1, Chen P1, Fu L2, Zhao H3, Zou Z2, Mei C2.
- Molecular medicine reports.Mol Med Rep.2014 Sep;10(3):1626-1634. doi: 10.3892/mmr.2014.2354. Epub 2014 Jun 26.
- Mesangial proliferative glomerulonephritis (MsPGN) is characterized by widespread mesangial cell proliferation and an accumulation of extracellular matrix (ECM) in the mesangial area. In a previous study we developed a polycystin‑1 N‑terminal fragment (PC‑1 NF) fusion protein that inhibits the
- PMID 24970599
Japanese Journal
- Yellow Wine Polyphenolic Compounds Inhibit Matrix Metalloproteinase-2, -9 Expression and Improve Atherosclerotic Plaque in LDL-Receptor-Knockout Mice
- Zhai Xiaoya,Chi Jufang,Tang Weiliang [他]
- Journal of pharmacological sciences 125(2), 132-141, 2014-06
- NAID 40020097585
- Proteolytic and Non-proteolytic Activation of Keratinocyte-Derived Latent TGF-β1 Induces Fibroblast Differentiation in a Wound-Healing Model Using Rat Skin
- Hata Shozaburo,Okamura Kazuhiko,Hatta Mitsutoki,Ishikawa Hiroyuki,Yamazaki Jun
- Journal of Pharmacological Sciences, 2014
- … α-SMA expression was inhibited by an anti-αv-integrin antibody and a matrix metalloproteinase (MMP) inhibitor, GM6001. …
- NAID 130003391483
- A Novel Role of Sympathetic Activity in Regulating Mitral Valve Prolapse
- Hu Xiang,Wang Hao-Zhe,Liu Jun,Chen An-Qin,Ye Xiao-Feng,Zhao Qiang
- Circulation Journal, 2014
- … In view of the extracellular matrix remodel, sympathetic effects presented catabolic metabolism displaying significantly increased expressions of total, secretory and active MMP-2 protein (matrix metalloproteinase-2), as well as MMP-9 protein. … Diminished MMP inhibitor expression, TIMP2, also could reflect this effect in the norepinephrine medium. …
- NAID 130003391112
Related Links
- A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused ... The present ...
- Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2 ...
Related Pictures
★リンクテーブル★
[★]
- 英
- metalloproteinase inhibitor
- 関
- メタロプロテアーゼ阻害薬
[★]
- 英
- metalloproteinase inhibitor
- 関
- メタロプロテアーゼ阻害剤
[★]
- 関
- abrogate、block、depress、depression、deter、inhibition、interdict、prevent、prevention、repress、repression、restrain、restraint、suppress、suppression
[★]
- 関
- blocker、depressant、suppressant
[★]
メタロプロテアーゼ
[★]
メタロプロテアーゼ